Formulation, Characterization, and In Vivo Immunogenicity of Heat-Stabilized Dissolvable Microneedles Containing a Novel VLP Vaccine

新型病毒样颗粒疫苗的热稳定可溶性微针的制备、表征及体内免疫原性研究

阅读:1

Abstract

OBJECTIVE: Vaccination has significantly improved health outcomes, but implementing vaccination efforts in low and middle-income countries, particularly in warmer climates, presents challenges. Microneedle technology has been developed for its simple and relatively painless applications of vaccines. However, a few hurdles must be overcome before widespread acceptance, including evaluating the safety and biocompatibility of the polymer used to fabricate these microneedles. Additionally, it is important to demonstrate reliable immune responses comparable to or better than those achieved through traditional administration routes. This study aimed to develop and evaluate dissolvable microneedles loaded with a novel virus-like particle (VLP) vaccine, focusing on their fabrication, characterization, thermostability, and preclinical immunogenicity. METHODS: Microneedles were fabricated using the micro-molding technique with polyacrylic acid (PAA) polymer, incorporating a novel VLP vaccine targeting arbovirus. Characterization studies assessed microneedle sharpness, skin insertion force, and VLP integrity. We also investigated the thermostability of the vaccine after storing the microneedles at elevated temperatures for approximately 140 days. Vaccine immunogenicity was assessed in mice, and transdermal (microneedle) delivery was compared with intramuscular (hypodermic needle) delivery. RESULTS: The study successfully fabricated and characterized VLP-loaded microneedles capable of skin insertion while maintaining vaccine integrity after exposure to extreme storage conditions. These microneedles elicited robust and long-lasting antibody responses comparable to those achieved through intramuscular administration. CONCLUSIONS: This study combines a novel VLP-based vaccine with dissolvable MNs fabricated under pH-neutral conditions, preserving antigen integrity and immunogenicity after high-temperature storage. This vaccine delivery platform addresses critical gaps in thermostability and needle-free vaccine delivery for resource-limited settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。